WESPAC Advisors’s iShares Biotechnology ETF IBB Stock Holding History

WESPAC Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,574	Closed	-$229K	–	168
2024 Q3	$229K	Buy	+1,574	New	+$228K	0.17%	138
2019 Q2	–	Sell	-6,975	Closed	-$750K	–	123
2019 Q1	$750K	Buy	+6,975	New	+$765K	0.52%	61
2016 Q1	–	Sell	-9,741	Closed	-$1.1M	–	109
2015 Q4	$1.1M	Buy	+9,741	New	+$1.06M	1.27%	32
2014 Q2	–	Sell	-11,829	Closed	-$932K	–	121
2014 Q1	$932K	Sell	11,829 -336	-3%	-$28K	0.81%	44
2013 Q4	$921K	Buy	12,165 +936	+8%	+$66.4K	0.77%	51
2013 Q3	$785K	Buy	11,229 +1,209	+12%	+$79.2K	0.92%	41
2013 Q2	$581K	Buy	+10,020	New	+$579K	0.88%	47

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

WESPAC Advisors's IBB Position: Q4 2024 in Review

WESPAC Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 1,574 shares — an estimated $229K sold.

WESPAC Advisors first reported a position in IBB in Q2 2013 and held it in 7 quarters. The position peaked at $1.1M in Q4 2015. 878 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

WESPAC Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
WESPAC Advisors sold 1,574 iShares Biotechnology ETF shares in Q4 2024, an estimated $229K.
WESPAC Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 7 quarters.
WESPAC Advisors's iShares Biotechnology ETF position peaked at $1.1M in Q4 2015.
878 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on WESPAC Advisors's 13F filing for Q4 2024, filed 4 Feb 2025.